|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-11-19 EST
|
5-day change | 1st Jan Change | ||
| 8.200 SEK | +0.86% |
|
-0.73% | -23.79% |
| 10-14 | Integrum's implant shows high survival in study of Ukrainian war veterans | FW |
| 10-14 | Integrum AB Announces Clinical Study Results of Opra Implant System in Ukrainian War Veterans | CI |
Company Valuation: Integrum AB
Data adjusted to current consolidation scope
| Fiscal Period: April | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 102.4 | 871.1 | 757.6 | 476.3 | 1,054 | 291.4 |
| Change | - | 751.01% | -13.03% | -37.13% | 121.38% | -72.36% |
| Enterprise Value (EV) 1 | 90.02 | 863.9 | 682.8 | 442.3 | 1,044 | 256.7 |
| Change | - | 859.7% | -20.96% | -35.22% | 136.03% | -75.42% |
| P/E | -6.53x | -407x | 35.9x | -29.6x | 260x | -8.99x |
| PBR | 4.31x | 35.9x | 4.79x | 3.36x | 7.39x | 1.64x |
| PEG | - | 4.7x | -0x | 0x | -2x | 0x |
| Capitalization / Revenue | 3.71x | 19.9x | 13x | 6.41x | 10.1x | 3.2x |
| EV / Revenue | 3.26x | 19.7x | 11.7x | 5.96x | 10x | 2.82x |
| EV / EBITDA | -5.75x | 23,821x | -99.3x | -17.6x | 1,098x | -6.22x |
| EV / EBIT | -5.57x | -1,829x | -91.7x | -17.5x | 1,512x | -6.18x |
| EV / FCF | -7x | -106x | -13.3x | -16.6x | -42.6x | -10.1x |
| FCF Yield | -14.3% | -0.94% | -7.53% | -6.02% | -2.35% | -9.87% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.039 | -0.1352 | 1.17 | -0.8832 | 0.22 | -1.52 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 27.61 | 43.8 | 58.39 | 74.27 | 104.1 | 91.1 |
| EBITDA 1 | -15.67 | 0.0363 | -6.878 | -25.07 | 0.9512 | -41.27 |
| EBIT 1 | -16.15 | -0.4724 | -7.445 | -25.29 | 0.6906 | -41.55 |
| Net income 1 | -15.69 | -2.141 | 21.27 | -16.18 | 4.032 | -30.82 |
| Net Debt 1 | -12.34 | -7.172 | -74.76 | -34.01 | -10.48 | -34.75 |
| Reference price 2 | 6.780 | 55.000 | 42.000 | 26.150 | 57.200 | 13.660 |
| Nbr of stocks (in thousands) | 15,097 | 15,838 | 18,038 | 18,215 | 18,435 | 21,334 |
| Announcement Date | 9/2/20 | 9/2/21 | 9/7/22 | 9/6/23 | 9/4/24 | 8/20/25 |
1SEK in Million2SEK
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 21.45M | ||
| 34.57x | 4.09x | 15.37x | 2.48% | 180B | ||
| 21.8x | 3.7x | 13.26x | 2.82% | 123B | ||
| 27.44x | 4.88x | 16.72x | 1.13% | 119B | ||
| 31.73x | 3.06x | 12.32x | 2.25% | 89.18B | ||
| 18.48x | 0.22x | 13.75x | 0.68% | 65.12B | ||
| 44.04x | 3.87x | 13.2x | 1.93% | 57.93B | ||
| 46.36x | 11.65x | 32.67x | -.--% | 54.33B | ||
| 28.13x | 6.96x | 17.65x | 1.43% | 48.88B | ||
| 48.35x | 3.5x | 12.88x | 0.49% | 36.07B | ||
| Average | 33.43x | 4.66x | 16.42x | 1.47% | 77B | |
| Weighted average by Cap. | 31.53x | 4.37x | 15.83x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- INTEG B Stock
- Valuation Integrum AB
Select your edition
All financial news and data tailored to specific country editions
















